Macrogenics Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Rockville, MD
MGNX chart
What traders are saying about $MGNX
Latest postsMacrogenics Inc news
- MacroGenics, Inc. Estimates – BX:M55
TradingView ·
- MacroGenics reports 25% response in clear cell gynecologic cancer trial
Mugglehead Investment Magazine ·
- MacroGenics, Inc. (MGNX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- MacroGenics reports interim results for lorigerlimab in cancer trial By Investing.com
Investing.com Nigeria ·
- MacroGenics Reports Encouraging Interim Phase 2 LINNET Data for Lorigerlimab in Clear Cell Gynecologic Cancer
Quiver Quantitative ·
- MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer
Yahoo Finance ·
- Four patients with clear cell gynecologic cancer responded; all four responses were ongoing at cutoff.
Stock Titan ·
- Daiichi ADC up a tree? Macrogenics’ could be TOP1 in HN
BioWorld News ·
- MacroGenics (MGNX) Reports Promising Interim Phase 1 Data for MG
GuruFocus ·
- MacroGenics reports phase 1 data for MGC026 in solid tumors By Investing.com
Investing.com Canada ·
- MacroGenics announces interim data from MGC026 study
TipRanks ·
- MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN
Yahoo Finance ·
Macrogenics Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $149.5M | $150.0M | $58.7M | $151.9M |
| Net income | -$74,620 | -$66,966 | -$9,058 | -$119.8M |
| Diluted EPS | $-1.18 | $-1.07 | $-0.15 | $-1.95 |
| Total assets (year end) | $256.8M | $261.7M | $298.4M | $280.5M |
| Cash and equivalents (year end) | $57.2M | $182.8M | $101.0M | $108.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Macrogenics Inc
- Ticker
- MGNX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rockville, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1125345
Frequently asked questions
What exchange is Macrogenics Inc listed on?
Macrogenics Inc trades on the Nasdaq under the ticker symbol MGNX.
What industry is Macrogenics Inc in?
Macrogenics Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Macrogenics Inc headquartered?
Macrogenics Inc's business address on file with the SEC is in Rockville, MD.
When does Macrogenics Inc's fiscal year end?
Macrogenics Inc's fiscal year ends on December 31.
How much revenue did Macrogenics Inc report?
Macrogenics Inc reported $149.5M in revenue for calendar year 2025, according to its SEC filings.